UNamur - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" Vivre le confinement "
Funding: La recherche comporte deux phases successives. La première repose sur un questionnaire tout public comprenant quelques questions fermées et une question ouverte permettant aux répondants d'exprimer leurs ressentis du confinement. Une seconde phase par entretiens semi-directifs est envisagée en fonction des résultats de la phase 1.
Contact: https://www.unamur.be/coronavirus/enquetes https://survey.unamur.be/index.php/462198?lang=fr  
Comment: A ce jour, plus de 400 réponses ont été enregistrées.

ULB
" I mostly helped setting up a testing facility within the Erasme campus and my laboratory "
Contact: Nicolas.baeyens@ulb.ac.be

Protagoras - IHECS
" This study aims at analyzing the impact of Covid-19 crisis on EU communication on the Green deal and on the reorientation of EU climate and environment policies. It is run in partnership with the Institute for European Studies (IEE-ULB). "
Funding: No
Contact: Project coordinator: Nicolas Baygert PhD lecturer (IHECS, ULB, Paris Sciences-Po, CELSA), Director of Protagoras. nicolas.baygert@galilee.be

USL-B 
" Bail et Covid-19. La crise sanitaire bouleverse notre quotidien et, entre autres conséquences, prive une partie de la population de tout ou partie de ses revenus. Une série de questions liées au bail d'habitation en découlent. Le locataire doit-il encore payer son loyer par exemple ? Les délais de préavis sont-ils maintenus ? Les autorités ont-elles prévu une aide financière pour les locataires peu en fonds ? Les expulsions domiciliaires ont-elles toujours cours ? Etc. "

UNamur
" Mathematical modelling of the covid-19 epidemic in Belgium (SIR-type models, age-structured, care centres consideration,...): monitoring, detection of new peak and scenario-based forecasting "
Publication References: Technical reports can be delivered on demand
Contact: nicolas.franco@unamur.be
Comment: Collaboration with GEES members on the mathematical modelling of the covid-19 epidemic in Belgium

UNamur
" APOBEC3 enzymes are innate immune effectors acting against viruses. They act by introducing mutations in viral genomes. We investigate the restriction activity of the APOBEC3 proteins on SARS-CoV-2 replication dynamics. "
Funding: UNamur
Contact: nicolas.gillet@unamur.be

USL-B 
" In the 4-year long research project "Fighting students' failure high rate - rethinking pedagogical relations", we explore and monitor i.a. the working and living conditions of university students, through qualitative and quantitative research tools. Particular attention is paid to the Covid's consequences on students' behavior and studying abilities. "
Funding: Université Saint-Louis - bruxelles
Contact: nicolas.marquis@usaintlouis.be

ULiège
" The group in ULiege is developing models for capturing the growth / dynamics of the covid19 epidemic. The specificity of this work concerns the situations in hospitals. Indeed, the models include data like patients in hospitals, in ICU (Intensive Care Units) or deceased. Forecasting trends or testing strategies is possible with this kind of models. Every day, analysis and plots are published on the Twitter account of Prof. Vandewalle @vdwnico "
Contact: Nicolas Vandewalle - nvandewalle@uliege.be Twitter : @vdwnico

LHUB-ULB - Royal Academy of Medicine of Belgium
" "The purpose of this study is to map the healthcare workers exposure risk in Saint-Pierre University Hospital by combining molecular methods with serological assays. In summary, the short-term objective is threefold: (1) Provide an estimate of the sero-prevalence at baseline among high-risk health care workers (2) Determine prospectively the incidence of new SARS-CoV-2 infections among high-risk health care workers (3) Estimate the healthcare worker exposure to the virus by serological data to help our five partner hospitals in their day-to-day management of the ongoing pandemic The mid-term objectives are: (1) Establish an accurate mapping of the spread of the virus among our population allowing to identify the chain of transmission, (2) Identify predictive immunological markers of susceptibility to infection and disease severity to inform vaccine strategies and, (3) Establish solid diagnosis algorithm that will help adequate lockdown...

Read more: O. Vandenberg, Pr. - N. Clumeck, Pr. - C. Montesinos, Pr. - N. Dauby, MD, PhD - C. Gilles, MD - C....

UMONS 
" On the basis of the official figures published by the national crisis committee, Olivier Debauche ("Computing, Software and Artificial Intelligence" department, Faculty Poytechnique, UMONS) has published a graph every day (Facebook, LinkedIn, etc.) which shows the evolution of the pandemic situation in Belgium by means of GeoAI. The goal is to show graphs and especially to explain why and how the curves evolve. "
Publication References: https://covid.engineering
Contact: Olivier DEBAUCHE UMons / Faculty of Engineering Infortech / ILIA Unit rue de Houdain 9 B-7000 Mons Belgium Phone: +32 65 37 40 59
Comment: Member of the consortium "covid-19 Mathematical Modelisation"

ULB/ERASME
" Severe COVID-19 patients have a greater risk of long-term health issues and sometimes develop permanent lung damage or fibrosis needing a long treatment to enhance their quality of life. The project aims to better quantify the breathing parameters of a patient to assess his revalidation evolution. A 3D image acquisition based system, provides contacless and non invasive measure. The system can be used as a complementary diagnosis tools as well for a quantitative follow up. "
Funding: So far the project is supported by volunteering inside the ULB/Laboratory of Image Synthesis and Analysis (LISA) and the Erasme Hospital
Contact: Olivier Debeir < odebeir@ulb.ac.be> & Olivier Van Hove < Olivier.Van.Hove@erasme.ulb.ac.be>

Erasme Hospital
" Precise the frequency of thrombosis events in COVID19 patients "
Funding: No need
Contact: olivier.duranteau@erasme.ulb.ac.be

UCLouvain - FNRS
" We investigated the respective role of socio-demographic, cognitive, and emotional factors that can facilitate or impair three health behaviors recommended to limit the spreading of the covid19 pandemic (hand-washing, limitation of public transports' use and limitation of social contacts) "
Funding: No funding
Publication References: summary to be published in special issue of LouvainMedical Full report to be submitted in health psychology journal
Contact: Olivier.Luminet@uclouvain.be

ULB
" We are developing a prototype, upon the request of Médecins Sans Frontières | MSF Belgique, with aim to monitor key parameters of a patient's health - levels of oxygen saturation in the blood, heart rate and temperature - in order to detect a potential covid19 infection, and to adapt the patient care accordingly. The prototype is wearable, battery powered, and send its data wirelessly. In this regard, the patient can be remotely monitored. "
Funding: Own funds
Publication References: None.
Contact: Primary contact: Antoine Nonclercq - anoncler@ulb.ac.be ULB BEAMS (Oriane Bastin - orianne.bastin@ulb.ac.be & Ken Hasselmann - ken.hasselmann@ulb.ac.be & Antoine Nonclercq - anoncler@ulb.ac.be & Michel Osée - mosee@ulb.ac.be & François Quitin - fquitin@ulb.ac.be) ULB LISA (Olivier Debeir - odebeir@ulb.ac.be & Rudy Ercek - rercek@ulb.ac.be) ULB Smart Campus (Jean Landercy - Jean.Landercy@ulb.be)

Coris BioConcept
" Early February we started the development of a rapid antigen detection assay for SARS-CoV-2. The COVID-19 Ag Respi-Strip Assay was validated in three University hospital laboratories and registered (CE mark) by end of March. The test is designed as a first line triage assay to be used for rapid (15 minutes) detection of SARS-CoV-2 on symptomatic patients. We are currently developing a serological assay that targets the immune response against several antigens of the virus. "
Publication References: https://jcm.asm.org/content/jcm/early/2020/05/11/JCM.00977-20.full.pdf https://www.frontiersin.org/articles/10.3389/fmed.2020.00225/full?utm_campaign=ba-cov-sci-fmed-respi-strip&utm_medium=cvlp&utm_source=fweb
Contact: https://www.corisbio.com/Products/Human-Field/Covid-19.php product-sales: covid19@corisbio.com science-R&D: pascal.mertens@corisbio.com